Aims of the CSPRG
Through our research we aim to reduce the numbers of people being diagnosed with bowel cancer, and the numbers of people dying from this disease.
We are running a number of research studies to achieve these aims. We are testing new ways to screen people for bowel cancer, which we anticipate will improve the effectiveness, acceptability and efficiency of screening. We are also looking at ways to support GPs in their role in earlier diagnosis of bowel cancer, and to improve diagnosis in people once they have been referred to hospital for further investigations, as well as looking for new ways to monitor people at higher risk of bowel cancer.
Our research has provided evidence that has led to changes in national and international policy on colorectal cancer screening and prevention.
The main research objectives of the CSPRG include:
- To identify ways to increase participation in the NHS bowel cancer screening programme;
- To investigate specific symptoms and the use of a Faecal Immunochemical Test (FIT) in GP practices to determine which patients require further tests for colorectal cancer;
- To determine whether FIT can be used instead of colonoscopy for surveillance among individuals with intermediate risk adenomas;
- To examine the long-term benefits of a once-only flexible sigmoidoscopy (bowel scope/Flexi-scope) screen to reduce the risk of getting bowel cancer or dying from this disease;
- To estimate the risks and benefits of using Computed Tomographic Colonography (CTC), which is also known as ‘virtual colonoscopy’, as a diagnostic test for bowel cancer;
- To identify whether specific symptoms can predict bowel cancer location to enable targeted tests.